Alyssa A Toorop

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Blood Brain Barrier

Multiple Sclerosis

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Journal of neurology, neurosurgery, and psychiatry

Neurology(R) neuroimmunology & neuroinflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (2) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (2) (2024)
Alyssa A Toorop, Samantha Noteboom, Martijn D Steenwijk, Job W Gravendeel, Bas Jasperse, Frederik Barkhof, Eva M M Strijbis, Theo Rispens, Menno Michiel Schoonheim, Zoé Léonie Elise van Kempen, Joep Killestein
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (2) (2024)
Alyssa A Toorop, Zoé Léonie Elise van Kempen, Maurice Steenhuis, Jessica Nielsen, L G F Sinnige, Gert van Dijk, Christiaan M Roosendaal, Edo P J Arnoldus, Elske Hoitsma, Birgit I Lissenberg-Witte, Brigit A de Jong, Bob W van Oosten, Eva M M Strijbis, Bernard M J Uitdehaag, Theo Rispens, Joep Killestein, null null
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Alyssa A Toorop, Laura Hogenboom, Karien Bloem, Merve Kocyigit, Nadine W M Commandeur, Anne Wijnants, Birgit I Lissenberg-Witte, Eva M M Strijbis, Bernard M J Uitdehaag, Theo Rispens, Joep Killestein, Zoé Léonie Elise van Kempen
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, Elske Hoitsma, Esther Mpe Zeinstra, Luuk C van Rooij, Caspar Ep van Munster, Anke Vennegoor, Jop P Mostert, Beatrijs Ha Wokke, Nynke F Kalkers, Erwin Lj Hoogervorst, Jeroen Jj van Eijk, Christiaan M Roosendaal, Jolijn J Kragt, Marijke Eurelings, Jessie van Genugten, Jessica Nielsen, Lgf Sinnige, Mark E Kloosterziel, Edo Pj Arnoldus, Gert W van Dijk, Willem H Bouvy, Mark Hj Wessels, Lynn Boonkamp, Eva M M Strijbis, Bob W van Oosten, Brigit A De Jong, Birgit I Lissenberg-Witte, Frederik Barkhof, Bastiaan Moraal, Charlotte E Teunissen, Theo Rispens, Bernard Mj Uitdehaag, Joep Killestein, Zoé Léonie Elise van Kempen
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS). Journal of neurology, neurosurgery, and psychiatry (2023)
Zoë Y G J van Lierop, Samantha Noteboom, Martijn D Steenwijk, Maureen van Dam, Alyssa A Toorop, Zoé LE van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard Mj Uitdehaag, Menno Michiel Schoonheim, Charlotte E Teunissen, Joep Killestein
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (14) (2022)
Alyssa A Toorop, Maurice Steenhuis, Floris C Loeff, Suzanne S Weijers, Joep Killestein, Theo Rispens, Zoé LE van Kempen
Fingerprick blood samples to measure serum natalizumab concentrations. Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Zoé LE van Kempen, Alyssa A Toorop, Finn Sellebjerg, Gavin Giovannoni, Joep Killestein
Extended dosing of monoclonal antibodies in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (13) (2021)
Alyssa A Toorop, Theo Rispens, Eva Mm Strijbis, Bob W van Oosten, Brigit A de Jong, Bernard Mj Uitdehaag, Joep Killestein, Zoé LE van Kempen
Natalizumab concentrations during pregnancy in three patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (2) (2021)
Alyssa A Toorop, Zoë Y G J van Lierop, Eva M M Strijbis, Charlotte E Teunissen, Axel Petzold, Mike P Wattjes, Frederik Barkhof, Brigit A de Jong, Zoé Léonie Elise van Kempen, Joep Killestein
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab. Neurology(R) neuroimmunology & neuroinflammation 8 (1) (2020)